Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

被引：0
|
作者：
Martijn van Essen
Eric P. Krenning
Willem H. Bakker
Wouter W. de Herder
Maarten O. van Aken
Dik J. Kwekkeboom
机构：
[1] Erasmus MC,Department of Nuclear Medicine
[2] Erasmus MC,Department of Internal Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2007年 / 34卷
关键词：
Lu-octreotate; Foregut carcinoid; Bronchial carcinoid; Gastric carcinoid; Thymic carcinoid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1219 / 1227
页数：8
相关论文
共 50 条
  • [1] Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin
    van Essen, Martijn
    Krenning, Eric P.
    Bakker, Willem H.
    de Herder, Wouter W.
    van Aken, Maarten O.
    Kwekkeboom, Dik J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (08) : 1219 - 1227
  • [2] Peptide receptor radionuclide therapy with 177Lu-octreotate in foregut carcinoid tumours
    Van Essen, M.
    Krenning, E. P.
    Bakker, W. H.
    Kooij, P. P.
    Kwekkeboom, D. J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S215 - S215
  • [3] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
    Del Prete, Michela
    Buteau, Francois-Alexandre
    Beauregard, Jean-Mathieu
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1490 - 1500
  • [4] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study
    Michela Del Prete
    François-Alexandre Buteau
    Jean-Mathieu Beauregard
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1490 - 1500
  • [5] Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine
    Sabet, Amir
    Dautzenberg, Kristina
    Haslerud, Torjan
    Aouf, Anas
    Sabet, Amin
    Simon, Birgit
    Mayer, Karin
    Biersack, Hans-Juergen
    Ezziddin, Samer
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (08) : 1238 - 1246
  • [6] Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine
    Amir Sabet
    Kristina Dautzenberg
    Torjan Haslerud
    Anas Aouf
    Amin Sabet
    Birgit Simon
    Karin Mayer
    Hans-Jürgen Biersack
    Samer Ezziddin
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1238 - 1246
  • [7] Peptide receptor radionuclide therapy of neuroendocrine tumours with 177Lu-octreotate: first experience in a French Canadian centre
    Del Prete, M.
    Buteau, F. A.
    Beauregard, J. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S725 - S725
  • [8] Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
    Samer Ezziddin
    Feras Khalaf
    Maria Vanezi
    Torjan Haslerud
    Karin Mayer
    Abdullah Al Zreiqat
    Winfried Willinek
    Hans-Jürgen Biersack
    Amir Sabet
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 925 - 933
  • [9] Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
    Ezziddin, Samer
    Khalaf, Feras
    Vanezi, Maria
    Haslerud, Torjan
    Mayer, Karin
    Al Zreiqat, Abdullah
    Willinek, Winfried
    Biersack, Hans-Juergen
    Sabet, Amir
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 925 - 933
  • [10] Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
    Sabet, Amir
    Ezziddin, Khaled
    Pape, Ulrich-Frank
    Ahmadzadehfar, Hojjat
    Mayer, Karin
    Poeppel, Thorsten
    Guhlke, Stefan
    Biersack, Hans-Juergen
    Ezziddin, Samer
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 1857 - 1861
12345